Skip to content

GUM Remote Testing v4.0

Verifying Remote Low Volume Blood Tests for Genito-urinary Infections Including Syphilis and Bloodborne Viruses

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06244966
Enrollment
40
Registered
2024-02-06
Start date
2024-05-31
Completion date
2025-05-31
Last updated
2024-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis B and Hepatitis C, HIV Infections, Syphilis Infection

Brief summary

Capillary blood sample results are compared to venous blood results

Detailed description

Capillary blood samples can be taken by patients from their own finger without requiring a healthcare professional to take a blood sample. Samples taken this way can be posted from home. This crucially avoids visits to the clinic or hospital to have blood samples taken. It would reduce the burden on healthcare professionals and is often preferred by patients. It is important to demonstrate that the results of an analysis performed on capillary blood samples are equivalent to the analysis of a standard venous sample. This study aims to collect, in parallel to a standard venous blood sample, a capillary blood sample taken by the participant which is then added to specially designed filter paper (dried plasma spot sample) or other collection devices. Parallel analysis of paired samples will then allow the investigators to assess if results measured in samples taken using the two methods are similar. The investigators will recruit 40 participants for each collection device to this study. It is important to obtain a range of positive and negative results from the study participants, and from stored samples and quality control material.

Interventions

DIAGNOSTIC_TESTHIV diagnostic testing

Finger-prick capillary blood will be tested alongside venous blood

Sponsors

Royal Devon and Exeter NHS Foundation Trust
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Comparative study of two collection methods for blood samples

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adults * Able and willing to provide informed consent. * Already having a venous blood sample for clinical care

Exclusion criteria

* Failure to consent

Design outcomes

Primary

MeasureTime frameDescription
Comparative capillary and venous samples screening testing1 yearTo have sufficient parallel samples (capillary and venous) collected to demonstrate equivalence of the results of HIV, HBV, HCV and syphilis testing using the Roche Cobas e601 platform

Secondary

MeasureTime frameDescription
Comparative capillary and venous samples confirmatory testing1 yearTo have sufficient parallel samples (capillary and venous) collected to demonstrate equivalence of the results of HIV, HBV, HCV and syphilis testing using other platforms and for viral load

Countries

United Kingdom

Contacts

Primary ContactCressida Auckland
cressida.auckland@nhs.net01392 406459
Backup ContactAlison Kerridge
rduh.research-eastern@nhs.net01392 403055

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026